| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T156-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 |
| filingDate |
2010-05-19^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2012-12-06^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2012530686-A |
| titleOfInvention |
Transdermal therapeutic system with controlled active substance flow comprising a basic reactive oxide |
| abstract |
The present invention comprises an active substance impervious occlusive backing layer, a monolayer or multilayer matrix, and a peelable protective film, wherein at least one of the matrix or matrix layer is a pharmaceutically usable salt. To a transdermal therapeutic system comprising a pharmaceutically active substance or a plurality of pharmaceutically active substances and a pharmaceutically usable alkali-reactive oxide. |
| priorityDate |
2009-05-27^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |